Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Return to: PBR Home | Automation
Today in Automation


Eisai, JCR to discover new CNS treatments using BBB penetration technology Eisai and JCR Pharmaceuticals have concluded a feasibility study agreement, which will examine the possibility of applying JCR's blood-brain-barrier (BBB) penetration technology 'J-Brain Cargo' to discover new treatments. Automation > IT & Software > News

Latest Automation News by Sector

Select a sector from the list or browse by sector below:

IT & Software

EyeGate gets USPTO notice of allowance for proprietary dexamethasone phosphate formulation
Eyegate Pharmaceuticals (EYEG), a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, announced that it has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application related to its lead product candidate, EGP-437.
Automation > IT & Software > News
Pulmatrix issued patents covering iSPERSE technology to treat patients with inhaled dry powders
Pulmatrix (PULM) has been granted two patents from the US Patent and Trademark Office (U.S. Patent # 8,992,983 and US patent # 9,061,352), which cover the composition of matter for the company's underlying iSPERSE (inhaled Small Particles Easily Respirable and Emitted) inhaled dry powder technology as well as methods for treating a subject using respirable dry powders.
Automation > IT & Software > News

Laboratory Instrumentation

Cepheid, pharma firms collaborate on diagnostic test for multidrug-resistant bacterial infections
By PBR Staff Writer
Cepheid has entered into a new collaboration with AstraZeneca, Cubist and GSK to encourage transformational change in infectious disease therapy.
Automation > Laboratory Instrumentation > News
BioLight announces start of clinical study with DiagnosTear dry eye syndrome diagnostic assay
BioLight Life Sciences Investments announced that DiagnosTear has received all necessary approvals from Sheba Medical Center near Tel Aviv to begin a clinical study with its TeaRx, point-of-care Dry Eye Syndrome diagnostic assay. DiagnosTear is part of BioLight’s XLVision Sciences ophthalmology cluster.
Automation > Laboratory Instrumentation > News